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Background: Cardiac Rehabilitation (CR) is a recommendation in international clinical practice 
guidelines given its’ benefits, however use is suboptimal. The purpose of this position statement 
was to translate evidence on interventions that increase CR enrolment and adherence into 
implementable recommendations.  
Methods: The writing panel was constituted by representatives of societies internationally 
concerned with preventive cardiology, and included disciplines that would be implementing the 
recommendations. Patient partners served, as well as policy-makers. The statement was 
developed in accordance with AGREE II, among other guideline checklists. Recommendations 
were based on our update of the Cochrane review on interventions to promote patient utilization 
of CR. These were circulated to panel members, who were asked to rate each on a 7-point Likert 
scale in terms of scientific acceptability, actionability, and feasibility of assessment. A web call 
was convened to achieve consensus and confirm strength of the recommendations (based on 
GRADE). The draft underwent external review and public comment. 
Results: The 3 drafted recommendations were that to increase enrolment, healthcare providers, 
particularly nurses (strong), should promote CR to patients face-to-face (strong), and that to 
increase adherence part of CR could be delivered remotely (weak). Ratings for the 3 
recommendations were 5.95±0.69 (mean ± standard deviation), 5.33±1.12 and 5.64±1.08, 
respectively.  
Conclusions: Interventions can significantly increase utilization of CR, and hence should be 
widely applied. We call upon cardiac care institutions to implement these strategies to augment 
CR utilization, and to ensure CR programs are adequately resourced to serve enrolling patients 















Cardiovascular diseases (CVD) are among the leading burdens of disease and disability 
globally.
1
  Cardiac rehabilitation (CR) is a model of secondary prevention to mitigate this 
burden. Outpatient (phase II) CR, regardless of delivery setting, is comprised of specific core 
components such as structured exercise, risk factor management, patient education and 
psychosocial counseling.
2,3
 Utilization of CR is associated with 25% lower cardiovascular 
mortality, 18% less hospitalization, and improved quality of life,
4
 among other benefits.   
Accordingly, CR is a recommendation in international CVD clinical practice guidelines. 
It is recommended for patients with acute coronary syndrome,
5,6,7





 and in specific populations such as women with CVD.
12
  
CR utilization is comprised of 4 elements (Figure 1).
13
 Patients must first be referred to 
CR by a healthcare provider. A Canadian Cardiovascular Society–Canadian Association of 
Cardiovascular Prevention and Rehabilitation (CACPR) position paper regarding promoting CR 
referral is available elsewhere.
14
 The patient-related aspects of CR utilization which are the focus 
of this position statement are three-fold: enrolment, adherence and completion (definitions in 
Figure 1).  
Although CR is strongly recommended after a cardiac event, its’ use is suboptimal. CR 
utilization rates vary by jurisdiction, owing to multi-level factors,
15
 and hence global utilization 
rates are not established. A meta-analysis of CR enrolment in the literature reported an overall 
rate of 42.3±18.7% (median=39.3%),
16
 and of adherence of 66.5±18.2% (median=72.5%) of 
prescribed sessions;
17
  however caution should be warranted in over-interpreting these rates as 














With regard to enrolment, the largest and most recent cohort where this was assessed 
using administrative data was in the United States, where enrolment rates of 16.3% were 
reported in Medicare beneficiaries (≥65 years) post-myocardial infarction or revascularization.
18
 
Again, the only population-based data of which we are aware with verified adherence stems from 
the United States, and showed that 40% of Medicare beneficiaries attended ≥30/36 and 13% of 
included participants attended <6 of 36 prescribed sessions.
19
 The ASPIRE-2-PREVENT study 
in 19 randomly-selected hospitals in the United Kingdom reported that while 70% were 
“advised” to attend, 52% of all patients self-reported attending half of prescribed sessions
20
 
(which is only on average about 10);
21
 EUROASPIRE-IV which assessed cardiac patients from 
78 hospitals across 24 European countries revealed that while 51% were advised to attend CR, 
41% of all patients self-reported attending half of prescribed sessions
22
 (these are likely over-
estimates due to socially-desirable responding).  
Representative population-based data on completion rates are available in the United 
Kingdom’s CR registry; results suggest 77% of participants complete CR
23
 (but caution is 
warranted in over-interpretation as sites may not enter data for patients who only attend an initial 
session). Utilization rates are even lower in lower-income countries
24,25
 where the epidemic of 
CVD is at its’ worst.  
Rationale and Purpose  
Given the benefits of CR, benchmarks for utilization have been previously established. 
Indeed, the purpose of this position statement is to provide current, evidence-based guidance on 
interventions that will ensure these benchmarks are met. Specifically, the aim is that 70% of 
indicated patients enroll in CR
14
 (given that some patients may have legitimate contraindications; 














associated with even better benefit).
26
 We ambitiously set a target of CR completion by 70% of 
enrollees.  
The impact of achieving greater CR utilization is apparent. For example, based on 2005 
CR utilization rates post-myocardial infarction in Ontario, Canada, it was projected that if CR 
use was increased to a 90% benchmark, there would be 135 deaths prevented or postponed 
annually, with a 1.3% (95% confidence interval=1.0-1.6) reduction in CVD mortality.
27
 In a 
study conducted in the United States, the number of deaths that could be delayed or postponed if 
“perfect” guideline-based care (e.g., revascularization, optimal medication therapy, CR) was 
provided following acute cardiac events was estimated; Out of 10 treatments of known 
effectiveness for myocardial infarction, other than acute revascularization, the greatest number of 
patient deaths could be prevented or postponed with optimal CR utilization. Similarly, optimal 
CR utilization was estimated to prevent or postpone the greatest number of deaths in patients 
with unstable angina and heart failure, compared with other guideline-based treatments.
28
  
With regard to adherence, the dose-response relationship between CR use and outcomes 
has been well-established; the more sessions patients attend, the better their outcomes.
29,30
 A 
recent review examining CR dose showed adherence to a minimum of 12 comprehensive CR 
sessions was associated with a 42% reduction in all-cause mortality, and adherence to 36 
sessions was associated with a 35% reduction in percutaneous coronary intervention.
26
 Finally, it 
is also well-established that CR completers have lower death rates than non-completers.
31
  
Therefore, the objective of this position statement is to develop evidence-based 
recommendations on increasing patient enrolment in, adherence to and completion of CR. While 
















recommendations for “encouraging people to attend” CR, these were published in 2013 prior to 
the Cochrane review update and first meta-analysis on CR utilization interventions.
32
  
The recommendations provided herein are directed to healthcare practitioners providing 
inpatient acute cardiac care (e.g., nurses, physiotherapists, pharmacists, physicians), any 
referring providers (e.g., cardiologist, cardiac surgeon, physiatrist / physical medicine and 
rehabilitation specialist, internist, family physicians), and CR providers. CR promotion 
interventions should be initiated in the inpatient setting, and also delivered during CR.  
Methods 
Writing Panel Composition & Stakeholder Engagement 
 The writing panel was constituted based on the process of the CACPR Guidelines 
Executive Committee, and with input of the International Council of Cardiovascular Prevention 
and Rehabilitation (ICCPR) Executive Committee. They recommended representatives of major 
CR societies (where possible the corresponding authors of trials which were included in the 
Cochrane review
32
 which forms the evidentiary basis for this position statement were invited to 
represent their corresponding national CR association), while ensuring that the panel had diverse 
geographic representation, and included the healthcare provider types that would be 
implementing the recommendations (e.g., nurses, physiotherapists, physiatrists, among others). 
Panel co-chairs were approved by both committees (CSP, SLG).  
Patient partners (JS, PM) were solicited to serve as well as policy-makers (AA, NZ, SC, 
BR, SB, AG) to ensure implementability and uptake of the recommendations. The World Health 
Organization and World Heart Federation were informed about the initiative, with a request for 














All members were required to disclose conflicts of interest, financial relationships or 
personal interests from 12 months before initiation of the writing effort that could impact their 
contributions to this statement at the time of statement initiation. These were collated and 
reviewed on a web call of the writing panel. Only 1 was raised, and was considered not to 
influence the writing of the statement (declaration available from corresponding author upon 
request). Finally, an external review panel was also populated, comprised of scientific and 
clinical experts, as well as representatives of relevant organizations and agencies. 
Evidence collection, Grading criteria and Synthesis 
This position statement is based on the results of the Cochrane systematic review update 
with meta-analysis on interventions to promote patient utilization of CR undertaken by the co-
chairs.
32
 In brief, comprehensive literature searches were performed in July 2018 of 6 databases. 
The search strategy consisted of 4 elements: (1) Cardiovascular diseases, (2) Patient compliance 
(enrolment, adherence and completion outcomes), (3) Rehabilitation, (4) Motivational 
interventions and education.  
Articles were included in the review if the following criteria were met: (i) included 
patients had a CR-qualifying condition, (ii) there was an intervention targeted to patients / 
groups, their partners / caregivers or other family members, or healthcare professionals with the 
specific aim of increasing patient utilization of phase 2 comprehensive CR, (iii) their design was 
randomized or quasi-randomized. The Population, Intervention, Comparator and Outcomes 
(PICO) can be found there. Risk of bias in each included trial was assessed using Cochrane’s 
tool.
33
 Evidence for each outcome was evaluated according to the Grading of Recommendations 
















Development Process  
The statement was developed in accordance with the Appraisal of Guidelines for 
Research and Evaluation (AGREE)-II,
35
 the Institute of Medicine’s Trustworthiness Standards
36
 
and the Reporting Items for practice Guidelines in HealTh care (RIGHT) reporting guidelines.
37
 
Recommendations were initially developed by the panel co-chairs, with certainty of evidence 
and strength of recommendation ratings based on GRADE.
34
 Exclusions were also drafted for 
rating. The 3 drafted recommendations and exclusions were circulated to all other authors, who 
were asked to rate each on a 7-point Likert scale in terms of scientific acceptability, actionability, 
and feasibility of assessment
38
 (higher scores more positive). Additionally, overall comments 
were requested. The ratings and comments from the authors were collated anonymously and 
shared with authors. It was established a priori that recommendations with mean overall ratings 
<5/7 would not be accepted as is.
39
 A web call was convened to discuss areas where consensus 
was lacking (as per standard deviations below, there was very high consensus), revisions based 
on comments provided, and to confirm strength of the recommendations. The senior author 
chaired the call to ensure all perspectives were voiced. The recommendations were revised 
accordingly.  
The position statement outline was developed by the co-chairs as well. Benefits and 
harms of the recommendations were considered, as well as costs and implementability. The first 
draft of the position statement was circulated to the writing panel for input concurrent with the 
recommendations. Feedback was incorporated by the co-chairs. A written record of feedback and 
corresponding edits has been archived. The revised position statement was circulated to the 
writing panel for discussion on the web call, as well as to an independent external review panel 














With integration of further input, it was submitted to the ICCPR Executive Committee 
and CACPR Guideline Executive for approval, and then to the major cardiac societies globally 
for endorsement consideration. The draft was also posted on ICCPR’s website for a 45-day 
period to enable interested public stakeholders to provide input. Input received from associations 
and stakeholders was documented and considered, and integrated where appropriate. Input did 
not result in substantive alteration to the recommendations, but some sections of the text were 
clarified. The writing panel will consider updating this position statement in accordance with 
updates to the corresponding Cochrane review, where changes to conclusions are found, new and 
superior interventions are identified or harms raised.
32
  
CR Utilization Recommendations  
As outlined below, effective strategies to increase patient utilization of CR were identified for 
each indicator/outcome.
32
 Therefore, all inpatient and outpatient settings as applicable treating 
CR-indicated patients should be implementing these strategies to promote utilization. 
Recommendations are shown in Table 1. Overall ratings for the 3 recommendations were 
5.95±0.69 (mean ± standard deviation), 5.33±1.12 and 5.64±1.08 on the 7-point scale 
respectively, all exceeding the threshold for inclusion (see Table 2 for component ratings). For 
each recommendation, comments received formed the basis for revision (see differences between 
Table 1 and Table 2).  
All authors of successful interventions (i.e., point estimate on right side of line of unity 
and confidence intervals did not cross) were contacted to request their materials used, along with 
their permission to post them open source for use by others. Received tools are available at 















The meta-analysis demonstrated that enrolment interventions resulted in 27% greater 
utilization than was observed with usual care.
32
 Subgroup analyses revealed interventions were 
most successful if they targeted nurses (sometimes with peers or allied healthcare providers; no 
trials intervened with physicians), to deliver them face-to-face, although these were only trends 
(i.e., p>.05 but <.1).  





); coordination of the transfer of care between the hospital and general 
practice (where CR was provided);
43
 reducing the time to start CR (within 10 days);
44
 peer 





 and Theory of Planned Behavior-based letters.
47
   
Adherence Strategies 
The meta-analysis demonstrated that adherence interventions resulted in significantly 
greater utilization than was observed with usual care.
32
 Successful interventions included: a 
gender-tailored CR program;
48
 a brief program
49
 (there may be bias here in that it would be 
easier for patients to adhere to fewer sessions, and it key that patients participate in a sufficient 
number of sessions to achieve the benefits); cognitive-behavioral theory-based group
50
 and 
individual (tool available online)
51
 sessions; and exploitation of unsupervised settings
52,53
 (please 
see online supplement for subsequent references). Indeed, subgroup analyses revealed 
unsupervised delivery appears to be key, although this should be interpreted with caution as 
participation in a phone call is much easier for patients than attending a session on-site (i.e., low 















Again, the meta-analysis demonstrated that adherence interventions resulted 13% greater 
completion than is observed with usual care. Successful interventions included: theoretically-
based patient education (tool available online)
51
 and a smartphone-based intervention.
46
 None of 
the subgroup analyses were significant. 
Limitations  
The limitations of the evidence review are reported elsewhere.
32
 Chiefly, the 
interventions evaluated were varied and often multifaceted, resulting in high heterogeneity. 
Moreover, caution is warranted in over-interpretation of the meta-regression analyses, given 
there were few trials included, with relatively small sample sizes, and statistical significance was 
weak. 
Implementation Considerations 
Barriers to implementing these recommendations have been contemplated. Healthcare 
systems vary, in terms of inpatient length of stay, availability and reimbursement for CR 
services, as well as types of providers interacting with patients, which could all impact which 
interventions may be more feasible and effective. Benefit-harm considerations, cost implications, 
capacity issues, as well as applicability in low-resource settings are outlined in the supplemental 
material.   
Of particular importance, it is unclear what impact type of provider promoting CR would 














It is assumed this physician discussion with patients has not been tested in a trial due to greater 
perceived time constraints, but data from observational studies suggests physician 
encouragement in particular greatly impacts patient utilization.
54,55
 The feasibility and impact of 
CR promotion by all types of healthcare providers that treat cardiac patients should be 
considered in future.  
Exclusions 
Endorsement of CR should be given to all indicated patients as per the guidelines cited in 
the introduction, however there are a few valid instances where CR is contraindicated (i.e., 
severe mental illness/cognitive disorders [e.g., schizophrenia, advanced dementia; but not 
depression], comorbid terminal illness/palliative care [e.g., non-curable cancer with expected life 
expectancy <1 year], permanent resident in a long-term care facility). There can also be cardiac 
reasons that a patient may not be appropriate for the exercise portion of CR, but these patients 
should utilize all other core components (i.e., unstable angina, acute decompensated heart failure, 
cardiac infections, uncontrolled ventricular arrhythmias, aortic dissection, severe aortic stenosis, 
severe valvular regurgitation, acute thrombophlebitis, pulmonary or systemic embolism). These 
exclusions had an overall rating of 6.33/7 (Table 2). However, inability to ambulate (i.e., patient 
should receive non-exercise components; could use ergometer for upper extremity), lack of 
proficiency in the primary language in which the program is delivered (i.e., interpretation and 
translation services should be used), perceived lack of motivation (i.e., assuming patient would 
not be interested due to age or socioeconomic considerations) are not valid reasons to fail to 
promote CR utilization (overall rating 5.92/6).    














Patients need to be aware of the existence of CR, and its’ benefits. Intervention tools and 
scripts should be tailored to match patients’ culture/language (i.e., translations, adaptations) and 
gender (i.e., consideration of women’s unique needs),
56
 among other sociodemographic 
characteristics (e.g., socioeconomic status, rurality), and delivered in a patient-centered manner 
(i.e., make sure patients have sufficient time to ask questions about CR, and that their emotions 
related to recovery from a life-threatening cardiac event are validated and addressed).
57
 It may be 
helpful if the provider or peer discussing CR with patients is of a similar sex
58
 or ethnocultural 
background so they can understand some of the barriers patients may raise. Indeed, interventions 
to increase utilization should also take into consideration patient’s barriers (e.g., transportation, 
return-to-work, costs).
59
 Where possible, informal caregivers should be involved in CR 
discussions.  
Patient’s emotional and cognitive state should also be considered. Many patients 
experience anxiety due to worry of repeat events, and CR is a setting where patients are 
monitored by clinical staff and are supported to feel more comfortable in resuming activities of 
daily living. Moreover, approximately 20% of patients (even higher in heart failure) experience 
depression.
60
 This can lead to low motivation, feelings of helplessness and psychomotor 
retardation – all factors which can impede CR participation but also be ameliorated by it. With 
regard to cognition, patients may have difficulty understanding and remembering discussions 
about CR if they have mild cognitive impairment (which may be temporarily caused by bypass 
surgery or cardiopulmonary resuscitation), have been sedated or are on medications which have 
cognitive effects, or dementia (depression can also impact cognition and decision-making). 














for patients to take home, and again inclusion of informal caregivers in referral discussions, 
could mitigate these cognitive issues.  
Once referred, patients should be given the choice to attend a centre-based or home-based 
CR program based on their needs and preferences (including geographic barriers), particularly 
considering the results of the subgroup analysis showing adherence interventions are most 
effective when at least part of it is offered in an unsupervised setting (e.g., eCR). Patients 
electing home-based programs still need support (from peers and providers) to promote 
adherence.   
Potential Organizational Barriers to Applying the Recommendations  
 
In addition to capacity constraints within CR programs, limited inpatient human 
resources (staff availability, time), lack of clarity on referral processes and which providers are 
(and should be) discussing CR with patients, as well as lack of provider awareness regarding 
which patients are indicated and the nature of services delivered could hamper enrolment 
recommendation implementation. Moreover, many CR programs do not offer any, or have much, 
unsupervised CR capacity.
61
 Some guidance is available on best practices in delivery of CR in 
unsupervised settings through ICCPR’s provider certification program 
(http://globalcardiacrehab.com/training-opportunities/certification/). 
Implementation Tools 
As outlined above, the available tools used in the successful trials have been collated online. It is 
hoped that their availability will facilitate implementation of these recommendations and further 
























 Adoption can facilitate assessment of 
whether utilization rates meet recommended benchmarks, and the impact of utilization 
interventions. Financial incentives, such as pay-for-performance may enhance implementation.   
Finally, to support implementation, an online course was developed by the co-chairs to 
inform inpatient cardiac healthcare providers about the important role they play in promoting 
patient utilization of CR over-and-above referral, and providing tangible recommendations on 
how to encourage patients to enroll at the bedside 
(http://learnonthego.ca/Courses/promoting_patient_participation_in_CR/story_html5.html). It 
informs healthcare providers about the nature of CR and the benefits of participation, which 
patients are eligible for CR utilization, key talking points (i.e., describe CR, its’ benefits, the 
reason for patient referral, and that they highly encourage their patient fully participate; an 
accompanying point-of-care checklist is embedded for clinicians to download), as well as 
responses to some common barriers patients may raise (e.g., patients who live afar can access 
home-based programming; costs). It is applicable to all relevant provider types. It seeks to ensure 
providers’ patients perceive they need CR, and that their providers strongly promote their 
participation. It is currently being evaluated, and if beneficial, will be disseminated more 
broadly.   
Research Directions  
First, more population-level data are needed on CR utilization rates globally, which will 
also enable robust assessment of the impact of utilization interventions. With regard to 
interventions to increase CR utilization specifically, some interventions tested in the included 














available open source for future testing. Trials are needed to determine whether successful 
interventions can be replicated, and to establish generalizability as well.  
Research is needed to establish and test simple, brief, specific talking points for providers 
and text for patients to encourage enrolment. This would be more amenable to translation and 
cross-cultural adaptation, which could have much broader application and impact. The impact of 
type of provider promoting CR referral also requires more investigation.  
Finally, while overall CR utilization is sub-optimal there remain vulnerable populations 
who are often under-represented in CR. This includes patients of low socio-economic status, 
ethnoculturally-diverse, and “complex” patients (e.g., comorbidities, smokers). More trials are 
needed to establish whether offering gender-tailored CR is associated with increased utilization 
in women.  
Conclusions 
CR utilization is sub-optimal, despite the established benefits. Interventions can 
significantly increase utilization of CR, and hence should be widely applied. Enrolment 
interventions should be delivered face-to-face by a nurse, and adherence may be improved 
through remote delivery of CR. We call upon cardiac care institutions to implement these 
strategies to augment CR utilization, and to ensure CR programs are adequately-resourced to 
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Figure Title and Legend: 
FIGURE 1 – Definition of Cardiac Rehabilitation Utilization Indicators 





















Table 1: Recommendations for cardiac rehabilitation utilization interventions with level of 
evidence and evidence sources 
 
Recommendation Certainty of the 
Evidence 
(GRADE) 




1. Interventions to increase CR enrolment 
should target healthcare providers, 
particularly nurses, but also allied 
healthcare providers, to impact delivery 
to indicated
a
 patients. Their messages 
promoting enrolment could be 











Jolly et al., 
1999
43




2. Interventions to increase CR enrolment 











Jolly et al., 
1999
43




3. To increase CR adherence, 
interventions should be delivered 
remotely, or some of the CR program 

























































Recommendation (initial draft) 
1. Enrolment interventions 
should target healthcare 
providers, to impact 
delivery to patients 
5.57 ±1.45 (6) 6.20 ±0.65 (6) 5.86 ±0.83 (5.5) 5.95 ±0.69 (6) 
2. Enrolment interventions 
should be delivered by a 
nurse, potentially in 
conjunction with an allied 
healthcare provider or peer 
4.87 ±1.54 (5) 5.53 ±1.25 (6) 5.07 ±1.33 (5.5) 5.33 ±1.12 (6) 
3. To increase adherence, 
interventions should be 
delivered remotely or at 
least some of the CR 
program should be 
delivered unsupervised 
5.50 ±1.20 (6) 5.64 ±1.36 (6) 5.38 ±1.29 (5.5) 5.64 ±1.08 (6) 
Exclusions (initial draft)    
1. CR is contraindicated 
for some cardiac (i.e., 
unstable angina, acute 
decompensated heart 
failure, cardiac infections, 















aortic dissection, acute 
thrombophlebitis, 
pulmonary or systemic 
embolism), and other 
reasons (i.e., severe mental 




terminal illness / palliative 
care, living in long-term 
care) 
2. Inability to ambulate 
(i.e., patient should receive 
non-exercise components), 
lack of proficiency in the 
primary language in which 
the program is delivered 
(i.e., interpretation and 
translation services should 
be used), perceived lack of 
motivation (i.e., assuming 
patient would not be 
interested due to age or 















considerations) are not 
valid reasons to fail to 
promote CR utilization 
 
Rating values expressed by mean, standard deviation and median. CR: cardiac rehabilitation; NA: not applicable 














Scientific acceptability: Evidence base: high-quality evidence is available to support the recommendation. Clarity 
of presentation: the definitions of the numerator and denominator are specific and unambiguous. Validity: the 
recommendation accurately reflects the intended aspects of care being evaluated. Reliability: the recommendation is 
highly reproducible when utilized by intended users. 
Importance / Actionability: Health importance:  the recommendation addresses a clinically-important aspect of 
health considering the variation of care and the prevalence, incidence and effect on the burden of illness. Relevance: 
the recommendation addresses an area of significant importance for stakeholders, including policy-makers, 
managers, clinicians, patients and the public. Actionability: information produced by the recommendation can be 
used by intended users (e.g., policy-makers, clinicians) to improve care. 
Feasibility of Assessment: Data collection effort: the data collection effort is reasonable considering the potential 


















 Cardiac rehabilitation (CR) is grossly under-utilized, despite its’ proven benefits 
 
 A recently-updated Cochrane review established interventions to increase use 
 
 These were translated into implementable recommendations, using best practices.  
 
 Implementation tools include an online course to educate inpatient care providers 
 
 Patient preferences and barriers should be considered to optimize use 
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